A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva

9.5K views

⸱

DOI:

10.3791/57157

⸱

April 3rd, 2018

 ,  , 
1Department of Pharmacology, The Nippon Dental University, 2Department of Oral and Maxillofacial Surgery, The Nippon Dental University Hospital

In This Article

Summary

The goal of the protocol is to build an inflammatory human gingiva model in vitro. This tissue model co-cultivates three types of human cells, HaCaT keratinocytes, gingival fibroblasts, and THP-1 macrophages, under three-dimensional conditions. This model can be applied to investigating periodontal diseases, such as gingivitis and periodontitis.

Abstract

Periodontal diseases (such as gingivitis and periodontitis) are the leading causes of tooth loss in adults. Inflammation in gingiva is the fundamental physiopathology of periodontal diseases. Current experimental models of periodontal diseases have been established in various types of animals. However, the physiopathology of animal models is different from that of humans, making it difficult to analyze cellular and molecular mechanisms and evaluate new medicines for periodontal diseases. Here, we present a detailed protocol for reconstructing human inflammatory tissue equivalents of gingiva (iGTE) in vitro. We first build human tissue equivalents of gingiva (GTE) by utilizing two types of human cells, including human gingival fibroblasts (HGF) and human skin epidermal keratinocytes (HaCaT), under three-dimensional conditions. We create a wound model by using a tissue puncher to punch a hole in the GTE. Next, human THP-1 monocytes mixed with collagen gel are injected into the hole in the GTE. By adimistration of 10 ng/mL phorbol 12-myristate 13-acetate (PMA) for 72 h, THP-1 cells differentiated into macrophages to form inflammatory foci in GTE (iGTE) (IGTE also can be stumilated with 2 µg/mL of lipopolysaccharides (LPS) for 48 h to initiate inflammation). IGTE is the first in vitro model of inflammatory gingiva using human cells with a three-dimensional architecture. IGTE reflects major pathological changes (immunocytes activition, intracellular interactions among fibryoblasts, epithelial cells, monocytes and macrophages) in periodontal diseases. GTE, wounded GTE, and iGTE can be used as versatile tools to study wound healing, tissue regeneration, inflammation, cell-cell interaction, and screen potential medicines for periodontal diseases.

Introduction

Periodontal diseases are the leading cause of tooth loss in adults. Gingivitis and periodontitis are the most common periodontal diseases. Both present biofilm-mediated acute or chronic inflammatory changes in gingiva. Gingivitis is characterized by acute inflammation, whereas periodontitis usually presents as chronic inflammation. On the histological level,bacterial components trigger the activation of immune cells, such as macrophages, lymphocytes, plasma cells, and mast cells1,2. These immune cells, especially macrophages, interact with local cells (including gingival epithelial cells, fibroblasts, endothelial cells, and osteoblasts) resulting in inflammatory lesions in periodontal tissue3,4. Experimental models of periodontal diseases have been established in various types of animals, such as rats, hamsters, rabbits, ferrets, canines, and primates. However, the physiopathology of animal models is different from that of humans, making it difficult to analyze cellular and molecular mechanisms and evaluate new medicines of periodontal diseases5. Co-cultivation of periodontal bacteria and monolayer human oral epithelial cells has been used to investigate the mechanism of periodontal infections6. Nevertheless, monolayer cultures of oral cells lack the three-dimensional (3D) cellular architecture of intact tissue; therefore, they cannot mimic the in vitro situation.

Here, 3D inflammatory human tissue equivalents of gingiva (iGTE) are established to represent periodontal diseases in vitro. This 3D model of periodontal diseases occupies an intermediate position between monolayer cell cultures and animal models. Three types of human cells, including HaCaT keratinocytes, gingival fibroblasts, and THP-1 macrophages, are co-cultivated on collagen gel, and stimulated by inflammatory initiators to build iGTE. IGTE closely simulates the in vivo conditions of cell differentiation, cell-cell interaction, and macrophage activation in gingiva. This model has many possible applications for drug screening and testing new pharmacological approaches in periodontal diseases, as well as for analyzing cellular and molecular mechanisms in wound healing, inflammation, and tissue regeneration.

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol is designed to create human gingival tissue equivalents, gingival wound models, and gingivitis models. Human skin epidermal keratinocytes (HaCaT) were kindly provided from Professor Norbert E. Fusenig of Deutsches Krebsforschungszentrum (Heidelberg, Germany)7. Human gingival fibroblasts (HGFs) were isolated from gingival tissues according to the previously published protocols8. Informed consent was obtained beforehand, and the study was approved according to the guidelines set by the Committee of Ethics, the Nippon Dental University School of Life Dentistry at Tokyo (Authorization Number: NDU-T2012-35). Protocol steps 1–3 should be performed in a cell culture hood.

1. Preparation of 3D Human Tissue Equivalents of Gingiva (GTE) (Figure 1A)

  1. Mix collagen type I-A gel with 10% concentrated MEM-alpha and 10% reconstruction buffer (2.2 g of NaHCO3 and 4.47 g HEPES in 100 mL 0.05 N NaOH) in a 15 mL sterile tube by pipetting. Keep the mixed collagen solution on ice until used.
  2. Place 24-well culture inserts (pore size 3.0 µm) into a 24-well plate.
  3. Remove HGFs from the culture surface using 0.25% trypsin-EDTA solution. Suspend the cells in 10 mL of culture medium A (MEM-alpha + 20% FBS + 1% GlutaMAX). Count the cells by a Bürker-Türk cell counter.
    1. Extract the desired quantity of cells (1-5 x105 cells/mL), then centrifuge for 4 min at 190 x g.
    2. Suspend the cells in the mixed collagen solution. Keep the mixture on ice until the next step.
  4. Add 0.5 mL of the cell-collagen mixture (0.5–2.5 x 105 cells/well) into the culture insert without producing any bubbles. Incubate the mixture for 10–30 min in a humidified atmosphere with 5% CO2 at 37 °C to coagulate the mixture into a gel.
    NOTE: Add the collagen mixture into the center of the culture insert to avoid unequal formation of collagen gel.
  5. Add 1 mL of the culture medium into the well and 0.5 mL into the insert. Incubate the culture plate for 24 h or overnight in a humidified atmosphere with 5% CO2 at 37 °C.
  6. Remove HaCaT cells from the culture surface using 0.25% trypsin-EDTA solution. Suspend the cells in 10 mL of medium B (DMEM + 10% FBS + 1% GlutaMAX) and count the cells. Extract the needed quantity of cells (1–5 x 105 cells/mL) with a pipette, centrifuge for 4 min at 190 x g. Suspend the cells in medium B.
  7. Remove the medium from the culture inserts, which contain the HGF-collagen mixture, by aspiration. Add 0.5 mL of HaCaT cell suspension (0.5–2.5 x 105 cells/well) on the top of the HGF-collagen mixture. Incubate the cultures for 24 h or overnight.
    NOTE: At this time point, the medium in the culture well should be medium A, while the medium in the culture insert should be medium B.
  8. Replace the culture medium with KSR medium (co-culture medium) (MEM-alpha + 15% KnockOut Serum Replacement + 1% GlutaMAX) + 5% FBS. Add 1 mL of the culture medium into the culture well and 0.5 mL into the culture insert. Incubate the cultures for 24–48 h.
  9. Replace the culture medium with KSR medium + 1% FBS. Add 1 mL into the culture well and 0.5 mL into the culture insert. Incubate the cultures for 24 h or overnight.
  10. Replace the culture medium in the culture well with 0.7–1 mL KSR medium. Remove the medium completely from the culture insert (the culture surface should be exposed to air). Incubate the cultures for 1–2 weeks. Change the medium in the culture well two times per week.
    NOTE: Do not let the medium level rise above the culture surface (the top layer composed of keratinocytes). Always keep the culture surface dry.

2. Preparation of Wounded GTE (Figure 1B)

  1. Prepare a 1–3 mm diameter tissue puncher. Sterilize it with an autoclave at 121 °C for 20 min.
  2. Push the tissue puncher perpendicularly into GTE about 300 µm deep, and punch a hole in the tissue to simulate a wound.
  3. At this step, use the wounded GTE for investigating wound healing and tissue regeneration. Alternatively, fix GTE using 10% formalin neutral buffer solution to perform histological analysis.

3. Preparation of Inflammatory GTE (iGTE) (Figure 1B)

  1. Cultivate THP-1 cells according to the previous report9.
  2. Mix collagen type I-A gel with 10% concentrated RPMI 1640, 10% reconstruction buffer (2.2 g of NaHCO3 and 4.47 g HEPES in 100 mL 0.05 N NaOH) and 10 ng/mL PMA. Keep the mixed collagen solution on ice until use.
  3. Count 1–2 x 106 THP-1 cells and centrifuge for 4 min at 190 x g. Suspend the cells in 1 mL of the mixed collagen solution. Keep the mixture on ice until the next step.
  4. Add 10–30 µL THP-1-collagen mixture into the wounded area of GTE. Replace the culture medium to 0.7–1 mL KSR medium containing 10 ng/mL of PMA.
  5. Incubate the mixture in a humidified atmosphere with 5% CO2 at 37 °C for 72 h.
  6. Use the model for investigating gingivitis or periodontal disease (for example, add potential anti-inflammatory medicine to iGTE to see its effects on cytokine release10). Alternatively, omit 72 h PMA-treatment, add 2 µg/mL of LPS into the culture, and incubate the tissue in a humidified atmosphere with 5% CO2 at 37 °C for 48 h11,12.

4. Fixation and Whole Mount Immunostaining of GTE and iGTE Cultures

  1. Fixation of the cultures.
    1. Remove the culture medium from the 24-well plate. Wash the tissues 2 times with phosphate buffered saline (PBS).
    2. Add 1 mL of 10% formalin neutral buffer solution to the insert and 1 mL to the culture well. Leave the 24-well plate in a refrigerator at 4 °C overnight.
    3. Remove the 10% formalin neutral buffer solution the following day.
    4. For whole mount immunostaining, wash the tissues 3-4 times with PBS after fixation.
    5. For hematoxylin and eosin (H&E) staining and regular immunostaining, proceed with dehydration, paraffin embedding, and sectioning.
      NOTE: For whole mount immunostaining, this step can be omitted.
  2. Whole mount immunostaining
    NOTE: This protocol was modified from the one in reference 13.
    1. Wash the tissues 3x in PBS 0.5–1% Triton, 10–30 min each time.
    2. Incubate the tissues twice for 30 min in blocking buffer (PBS 1% Triton + 10% BSA), at room temperature.
    3. Wash the tissues 2× in blocking buffer, 5–10 min each time.
    4. Add 50 µL of primary antibody solution at the required dilution/concentration to the inserts. Use a thin plastic cling film to wrap the inserts to avoid drying out the tissue.
    5. Incubate the tissue for 1 to 2 days at 4 °C.
    6. Wash the tissues 3 times, for 30 min in PBS 1% Triton + 10% BSA. Wash again 3 times, for 5 min in PBS 1% Triton.
    7. Add 50 µL of secondary antibody in blocking buffer (PBS 1% Triton + 10% BSA) and 5 µL of Hoechst 33342 solution (NucBlue Live Cell stain) to each insert. Use a thin plastic cling film to wrap the inserts to avoid drying out the tissue.
    8. Incubate for 1 to 2 days at 4 °C. Wrap the 24-well plate in a wet paper towel, and then put it into a plastic pack to be used throughout incubation.
    9. Wash the tissues 3 times, for 10 min in PBS 1% triton
    10. Use a sharp needle to cut the membrane of the culture insert to obtain the tissue. Place the membrane onto a slide.
      NOTE: The tissue should be on the membrane.
    11. Add 2–3 drops of fluorescence mount medium. Cover the tissue with a cover glass and store at 4 °C in the dark until analysis.
    12. View tissues with a confocal laser scanning microscopy (LSM).

Access restricted. Please log in or start a trial to view this content.

Results

HaCaT cells displayed typical keratinocyte morphology under phase-contrast microscopic observation (Figure 2A). Scanner electron microscopic (SEM) images showed that HaCaT cell surfaces were covered by many microvilli. Intercellular connections between HaCaT cells were mediated by membrane processes (Figure 2B). HaCaT cells expressed gingival epithelium marker K8/1814, indicating that HaCaT cells are suita...

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol is based on methods of creating gingival tissue equivalents and subcutaneous adipose-tissue equivalents described by previous reports8,21,22. Although this is a simple and easy method, some steps require special attention. For example, the collagen mixture should be kept on ice until use to avoid gel formation in the solution. When adding the collagen mixture into the culture insert, make sure the solution was inje...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflict of interest.

Acknowledgements

This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (26861689 and 17K11813). The authors would like to thank Mr. Nathaniel Green for proofreading.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Collagen type I-ANitta Gelatin IncFor making dermis of GTE
MEM-alphaThermo Fisher Scientific11900073Cell culture medium
Cell Culture Insert (for 24-well plate), pore size 3.0 μmCorning, Inc.353096For tissue culture
GlutaMAXThermo Fisher Scientific35050061Cell culture reagent
DMEMThermo Fisher Scientific31600034Cell culture medium
KnockOut Serum ReplacementThermo Fisher Scientific10828028Cell culture reagent
Tissue puncherShibata system service co., LTDSP-703For punching holes in GTE
RPMI 1640Thermo Fisher Scientific31800022Cell culture medium
BSASigma-AldrichA3294For immunostaining
Hoechst 33342 (NucBlue Live Cell stain)Thermo Fisher ScientificR37605For labeling nuclei
Fluorescence mount mediumDakoFor mounting samples after immunostaining
Anti-Cytokeratin 8+18 antibody [5D3]abcamab17139For identifying epithelium
Scaning electron microscopeHitachi, Ltd.HITACHI S-4000For observing samples' surface topography and composition
Confocal laser scanning microscopyLSM 700; Carl Zeiss Microscopy Co., Ltd.LSM 700For observing samples' immunofluorescence staining
Anti-Cytokeratin 19 antibodyabcamab52625For identifying epithelium
Anti-vimentin antibodyabcamab92547For identifying fibroblasts and activated macrophages
Anti-TE-7 antibodyMilliporeCBL271For identifying fibroblasts in the dermis
Anti-CD68 antibodySigma-AldrichSAB2700244For identifying macrophages
Human CD14 AntibodyR&D SystemsMAB3832-SPFor identifying macrophages
Alexa Fluor 594-conjugated secondary goat anti-rabbit antibodyThermo Fisher ScientificA11012For immunofluorescence staining
Alexa Fluor 488-conjugated secondary goat anti-mouse antibodyThermo Fisher ScientificA11001For immunofluorescence staining
EVOS FL Cell Imaging SystemThermo Fisher ScientificFor observing the sample's immunofluorescence staining
THP-1 cellsRiken BRC cell bankRCB1189For making iGTE
PMA(Phorbol 12-myristate 13-acetate)Sigma-AldrichP8139For differentiatting THP-1 cells

References

  1. Cekici, A., Kantarci, A., Hasturk, H., Van Dyke, T. E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontology 2000. 64 (1), 57-80 (2014).
  2. Hasturk, H., Kantarci, A., Van Dyke, T. E. Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage. Frontiers in Immunology. 3, 118(2012).
  3. Koh, T. J., DiPietro, L. A. Inflammation and wound healing: The role of the macrophage. Expert reviews in molecular medicine. 13, e23(2011).
  4. Mescher, A. L. Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration. Regeneration. 4 (2), 39-53 (2017).
  5. Struillou, X., Boutigny, H., Soueidan, A., Layrolle, P. Experimental Animal Models in Periodontology: A Review. The Open Dentistry Journal. 4, 37-47 (2010).
  6. Han, Y. W., et al. Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells. Infection and Immunity. 68 (6), 3140-3146 (2000).
  7. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., Fusenig, N. E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 106 (3), 761-771 (1988).
  8. Xiao, L., Miwa, N. Hydrogen-rich water achieves cytoprotection from oxidative stress injury in human gingival fibroblasts in culture or 3D-tissue equivalents, and wound-healing promotion, together with ROS-scavenging and relief from glutathione diminishment. Hum Cell. 30 (2), 72-87 (2017).
  9. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., Tada, K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 26 (2), 171-176 (1980).
  10. Ara, T., Kurata, K., Hirai, K., Uchihashi, T., Uematsu, T., Imamura, Y., Furusawa, K., Kurihara, S., Wang, P. L. Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res. 44 (1), 21-27 (2009).
  11. Park, E. K., Jung, H. S., Yang, H. I., Yoo, M. C., Kim, C., Kim, K. S. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 56 (1), 45-50 (2007).
  12. Sharif, O., Bolshakov, V. N., Raines, S., Newham, P., Perkins, N. D. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. 8, 1(2007).
  13. Abcam. Whole mount fluorescent immunohistochemistry. , Available from: http://www.abcam.com/ps/pdf/protocols/whole_mount_fluorescent_ihc.pdf (2017).
  14. Shetty, S., Gokul, S. Keratinization and its disorders. Oman Med J. 27 (5), 348-357 (2012).
  15. Klinge, B., Matsson, L., Attström, R. Histopathology of initial gingivitis in humans. A pilot study. J Clin Periodontol. 10 (4), 364-369 (1983).
  16. Nagarakanti, S., Ramya, S., Babu, P., Arun, K. V., Sudarsan, S. Differential expression of E-cadherin and cytokeratin 19 and net proliferative rate of gingival keratinocytes in oral epithelium in periodontal health and disease. J Periodontol. 78 (11), 2197-2202 (2007).
  17. Goodpaster, T., Legesse-Miller, A., Hameed, M. R., Aisner, S. C., Randolph-Habecker, J., Coller, H. A. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem. 56 (4), 347-358 (2008).
  18. Langeland, K., Rodrigues, H., Dowden, W. Periodontal disease, bacteria, and pulpal histopathology. Oral Surg Oral Med Oral Pathol. 37 (2), 257-270 (1974).
  19. Holness, C. L., Simmons, D. L. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 81 (6), 1607-1613 (1993).
  20. Mor-Vaknin, N., Punturieri, A., Sitwala, K., Markovitz, D. M. Vimentin is secreted by activated macrophages. Nat Cell Biol. 5 (1), 59-63 (2003).
  21. Xiao, L., Aoshima, H., Saitoh, Y., Miwa, N. The effect of squalane-dissolved on adipogenesis-accompanied oxidative stress and macrophage in a preadipocyte-monocyte co-culture system. Biomaterials. 31 (23), 5976-5985 (2010).
  22. Xiao, L., Aoshima, H., Saitoh, Y., Miwa, N. Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent. Free Radic Biol Med. 51 (7), 1376-1389 (2011).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Inflammatory Gingiva Tissue EquivalentsHuman Gingival FibroblastsHaCaT KeratinocytesTHP 1 MonocytesCollagen Gel InjectionTissue Puncher Wound ModelPMA DifferentiationLPS StimulationH and E StainingImmunofluorescence Staining
Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva
Contact Us
Recommend to Library

Privacy

Terms of Use

Policies

Copyright © 2026 MyJoVE Corporation. All rights reserved.